Hostname: page-component-6766d58669-88psn Total loading time: 0 Render date: 2026-05-23T04:36:46.767Z Has data issue: false hasContentIssue false
  • English
  • Français

Transmission dynamics of COVID-19 among index case family clusters in Beijing, China

Published online by Cambridge University Press:  19 November 2020

Ying Cao ,
Yueh Wang ,
Aritra Das ,
Calvin Q. Pan  and
Wen Xie Open the ORCID record for Wen Xie [Opens in a new window]
Ying Cao
Affiliation:
Center of Liver Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China
Yueh Wang
Affiliation:
Biostatistics, Data Sciences, Safety & Regulatory, Research & Development Solutions, IQVIA, Taibei, Taiwan
Aritra Das
Affiliation:
Epidemiology and Outcomes Research, Real World Solutions, IQVIA, Haryana, India
Calvin Q. Pan
Affiliation:
Center of Liver Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China
Wen Xie*
Affiliation:
Center of Liver Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China
*
Author for correspondence: Wen Xie, E-mail: wenxie6218@163.com
Rights & Permissions [Opens in a new window]

Abstract

The outbreak of coronavirus disease-2019 (COVID-19) impacts public health dramatically around the world. The demographic characteristics, exposure history, dates of illness onset and dates of confirmed diagnosis were collected from the data of 24 family clusters from Beijing. The characteristics of the cases and the estimated key epidemiologic time-to-event distributions were described. The basic reproductive number (R0) was calculated. Among 89 confirmed COVID-19 patients from 24 family clusters, the median age was 38.0 years and 43.8% were male. The median of incubation period was 5.08 days (95% confidence interval (CI) 4.17–6.21). The median of serial interval was 6.00 days (95% CI 5.00–7.00). The basic reproductive number (R0) was 2.06 (95% CI 2.02–2.08). The median of onset-to-care-seeking days and the median of onset-to-hospital admission days were significantly reduced after 23 January 2020, which implied the enhanced public health awareness among families. With epidemic containment measures in place, the results can inform health authorities about possible extent of epidemic transmission within families. Furthermore, following initiation of interventions, public health measures are not only important for curbing the epidemic spread at the community level but also improve health seeking behaviour at the individual level.

Keywords

Basic reproductive numbercoronavirus disease 2019family clusterssevere acute respiratory syndrome coronavirus 2transmission dynamics

Information

Type
Original Paper
Information
Epidemiology & Infection , Volume 149 , 2021 , e74
Check for updates
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © The Author(s), 2021. Published by Cambridge University Press

Introduction

Since the second half of December 2019, a cluster of cases with ‘pneumonia of unknown aetiology’, potentially linked to a live animal market, started getting reported from the city of Wuhan in China which has since then spread to rest of China and countries across the globe [1]. The causative organism for these atypical pneumonia cases was subsequently identified as a novel coronavirus (2019-nCoV), later rechristened to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has been found to be different from two recent epidemic causing coronaviruses – MERS-CoV and SARS-CoV [Reference Zhu2]. This makes it the seventh identified member of the coronavirus family that can act as human pathogen. The corresponding disease has been called coronavirus disease 2019 (COVID-19).

The COVID-19 outbreak has become perhaps the greatest public health emergency in recent history, having given rise to more than 1.3 million confirmed cases and almost 80 000 deaths globally until 8 April 2020 [3]. Of these, nearly 82 000 cases and 3335 deaths have been reported from mainland China [4]. Proper understanding of the epidemiologic parameters of an infectious disease (such as reproduction numbers, incubation period, etc.) is an essential criterion for designing public health interventions. As the disease was first described in China, several studies have already described the epidemiologic parameters of COVID-19 disease in China, especially based on data from early stages of the epidemic [Reference Chan5–Reference Zhao9]. Some heterogeneity was noted in the parameters reported by the cited studies. For example, the value of R 0 or the expected number of secondary cases generated by an index case in a fully susceptible population, reported by the aforementioned studies varied between 2.2 [Reference Li6] and 3.8 [Reference Linton10]. This is not entirely unexpected as different populations may have different proportions of susceptible (or immune) individuals that may affect R 0. Also, the value of R 0 can evolve with epidemic progression owing to different environmental and biological factors [Reference Delamater11]. Despite the heterogeneity of findings, these studies shared one characteristic – all of them utilised data from Wuhan/Hubei province, which has been the epicentre of COVID-19 outbreak in China. Given the demographic and climatic diversity in China, the characteristics of the epidemic reported from Wuhan may not be applicable all across the country. Furthermore, different mutations of SARS-COV-2 have been identified from different countries/regions and pathogenicity has been found to vary according to the type of mutation [Reference Yao12], which also highlight the importance of describing the epidemiologic parameters at the regional level and, in turn, for public health decision-making. Against this backdrop, we utilised data from index case family clusters in Beijing to describe the several epidemiologic parameters including serial interval, incubation period, growth rate (r), epidemic doubling time (T d), R 0, etc.

Methods

Data source

The study dataset comprised of 120 individuals belonging to 24 families (clusters) who were hospitalised/quarantined in Beijing Ditan Hospital, affiliated to Capital Medical University in Beijing, which is a hospital designated for diagnosis and treatment of COVID-19 patients. The families were selected from line-list of hospital attendees based on following eligibility criteria: (1) presenting to the aforementioned hospital for either treatment or quarantine; (2) at least two family members diagnosed with COVID-19 and (3) date of COVID-19 diagnosis (availability of positive result) between 15 January 2020 and 14 February 2020. Besides diagnostic data (test results and corresponding dates), the following information were collected through interviews with 24 index patients and their family members: demographic information, time of illness onset and date(s) and type(s) of healthcare seeking related to current illness (both OPD visits and hospitalisation). A confirmed case of COVID-19 was defined as having at least two positive results for SARS-CoV-2 by real-time reverse transcription polymerase chain reaction (RT-PCR) assays, regardless of the clinical signs and symptoms of COVID-19 disease. The index case for each family cluster was defined as the RT-PCR positive family member with earliest exposure history or (in the absence of such history) presenting with symptoms before any other family members. The maximum follow-up period for detecting the emergence of secondary cases was 14 days. However, it was reported that the incubation period of COVID-19 can extend beyond 14 days [Reference Lauer13]. Therefore, in order to be conservative, the RT-PCR negative family members were followed for up to 45 days to ensure that there were no false-negatives. Among 120 individuals, there were 65 RT-PCR-positive secondary cases, 24 index cases and 31 RT-PCR negative cases.

Statistical analysis

The analysis focused on estimating the following epidemiologic parameters: serial interval, r, T d, R 0, onset-to-care-seeking interval and onset-to-hospital admission interval.

R 0 was calculated using the exponential growth methodology described by Wallinga and Lipsitch [Reference Wallinga14]. This method assumes that the number of infected subjects grows exponentially with r. This method also requires estimation of serial intervals or the time period between infection of an index case and a secondary case generated from the index case. We calculated serial interval using the following formula:

$$\eqalign{& {\rm Serial}\,{\rm interva}{\rm l}_{i{\rm th}\,{\rm family}} = \cr & {\rm Reported}\,{\rm date}\,{\rm of}\,{\rm infection}\,{\rm of}\,{\rm the}\,{\rm secondary}\,{\rm cas}{\rm e}_{i{\rm th}\,{\rm family}} - \cr & \quad{\rm Date}\,{\rm of}\,{\rm infection}\,{\rm of}\,{\rm the}\,{\rm index\ cas}{\rm e}_{i{\rm th}\,{\rm family}}\;\lpar {i = 1\,{\rm to}\,24} \rpar \comma \;} $$

where for the secondary cases, the date of infection was defined as either the date of testing for the first RT-PCR positive result or the date of symptom onset, whichever is earlier. Published studies on COVID-19 epidemic in China [Reference Linton10, Reference Lauer13] have reported the incubation period to be between 2 and 14 days. Therefore, to maintain biological plausibility, if the value of serial interval for any family turned out to be lower than 2 days, then that value was excluded from the analysis of serial interval.

Among 65 serial intervals, an empirical distribution consisting of 49 serial intervals was obtained by the above steps (16 serial intervals with serial intervals less than 2 days were excluded). The median of serial interval distribution and corresponding 95% bootstrapped confidence interval (CI) (obtained from 10 000 replicates) were calculated.

Furthermore, we assumed that the number of infected cases followed an exponential growth at a fixed growth rate. To mimic the exponential growth phase (assumed to be up to 10 days from the diagnosed date of index case), we transformed the obtained serial intervals in 10 days to cumulative incident cases, as shown in Figure 1, to estimate r using the least squares method [Reference Ma15]. Note that the family clusters were close population, the increasing trend of incident case number would be slow down, hence no exponential growth anymore if we included incidence data longer than 10 days. The following equation was used for the estimation of r:

$$r = \displaystyle{{X^{\rm T}Y} \over {X^{\rm T}X}}\comma \;$$

where superscript T denotes matrix transposition, X = {1, 2, …, 10}T is the vector of exponential growth period, recorded in days:

$$Y = \left\{{\log \displaystyle{{N\lpar 1 \rpar } \over {N\lpar 0 \rpar }}\comma \;\;\log \displaystyle{{N\lpar 2 \rpar } \over {N\lpar 0 \rpar }}\comma \;\;\ldots \comma \;\log \displaystyle{{N\lpar {10} \rpar } \over {N\lpar 0 \rpar }}} \right\}^{\rm T}\comma \;$$

where N(t) denotes the cumulative case number at tth day since the onset of infection, and N(0) is the index case number.

Fig. 1.

Cumulative incident cases by 10 days since first infection.

T d was estimated from r using the following equation:

$$T_{\rm d} = \displaystyle{{\ln 2} \over r}.$$

Finally, R 0 was calculated using the following equation:

$$R_0 = \lcub {M\lpar {-r} \rpar } \rcub ^{{-}1}\comma \;$$

where M is a moment generating function of the serial interval. We assumed empirical distribution of serial interval to derive M. The 95% CIs of R 0, r and T d were also using bootstrap with 10 000 replicates.

Incubation period

We calculated the incubation period using the simple mid-point imputation method described by Cai et al. [Reference Cai16]. Using this approach, the incubation period for each secondary case was obtained by the following formula:

$${\rm Incubation}\,{\rm period} = {\matrix{ {\lpar {\rm onset}\,{\rm date}-{\rm earliest}\,{\rm exposure}\,{\rm date}\; \rpar + }\cr{ \lpar {\rm onset}\,{\rm date}-{\rm latest}\,{\rm exposure}\,{\rm date} \rpar} } \over 2}.$$

Furthermore, to obtain the median and 95% CI, we modelled incubation period assuming a log-normal distribution. As before, 95% CI of median was obtained using bootstrap.

Onset-to-care-seeking interval and onset-to-hospital admission interval

The onset-to-care-seeking and onset-to-hospital admission intervals were modelled assuming Weibull distribution and were stratified by date of illness onset before or after 23 January 2020 (the day of lockdown initiation). The median value with corresponding 95% CI (via bootstrap with 10 000 replicates) was calculated for both parameters. The null distributions for the test of difference between median for the cases having onset before 23 January and after were also obtained using bootstrap.

All analyses were conducted using R version 3.4.1 software.

Results

The study population comprised of 24 index patients (one from each family cluster) and 96 family members. Among the family members, 65 were identified as secondary cases (which included 18 children below 15 years of age). The median age of the patients was 38.0 years (interquartile range (IQR) 29.0–58.0) and 39 (43.8%) of them were males. In total, 53 (59.6%) patients had recent travel history to Wuhan or reported having close contacts with individuals visiting from Wuhan. On stratifying the patients into pre- (illness onset before 23 January 2020) and post-lockdown periods, we found that the patients with pre-lockdown onset were significantly older, were more likely to be males and were more likely to report travelling to Wuhan or having contact with visitors from Wuhan compared to patients with post-lockdown onset.

The empirical distribution of serial interval is presented in Figure 2. The median serial interval was 6.00 (95% CI 5.00–7.00). Based on serial interval empirical distribution, the estimates (and 95% CI) of R 0, r and T d were 2.06 (2.02–2.08), 0.12 (0.11–0.12) and 6.00 days (5.59–6.60), respectively.

Fig. 2.

Serial interval empirical distribution.

The distribution of incubation period (fitted using log-normal distribution) is presented in Figure 3. The median incubation period was 5.08 days (95% CI 4.17–6.21).

Fig. 3.

Incubation period distribution (fitted using log-normal distribution).

The distributions of onset-to-care-seeking interval (fitted using Weibull distribution) in the pre- and post-lockdown periods are depicted in Figure 4. The median onset-to-care-seeking interval in the post-lockdown period was 3.16 days (95% CI 2.18–4.45), which was significantly shorter (P = 0.004) than those with illness onset in the pre-lockdown period (5.32 days; 95% CI 4.36–6.24). The Weibull distributions of onset-to-hospital admission interval for the pre- and post-lockdown periods are presented in Figure 5. As seen with onset-to-care-seeking, the median interval for onset-to-hospital admission was significantly shorter (P < 0.001) in the post-lockdown period (2.89 days; 95% CI 2.29–3.57) than that in the pre-lockdown period (6.28 days; 95% CI 4.40–8.41).

Fig. 4.

Distributions of onset-to-care-seeking interval (fitted using Weibull distribution).

Fig. 5.

Distributions of onset-to-hospital admission interval (fitted using Weibull distribution).

Discussion

The current study used mathematical modelling to determine several epidemiologic parameters and transmission dynamics of COVID-19 outbreak from data on 24 family clusters in Beijing. We also compared demographic and care-seeking parameters between the cases with illness onset before and after the lockdown, possibly the most important public health intervention towards epidemic containment. The natural history of disease in this patient population will be published separately. To the best of our knowledge, this is one of the first attempt to assess the epidemiologic characteristic of the epidemic in China using a dataset that did not have any representation from Wuhan (Table 1).

Table 1.

Demographics of family clusters with COVID-19 in Beijing as of 14 February 2020

Our data revealed that three out of five patients had either travelled to Wuhan or had contact with a visitor from Wuhan. However, the link with Wuhan was much more prominent among the patients having onset before lockdown (or the index cases) than among the patients who had post-lockdown onset, which suggests the presence of local human-to-human transmission in the later stage of the epidemic and supports implementation of interventions like social distancing for slowing the spread of infection. This corroborates with the findings from prior studies conducted in China and other countries [Reference Chan5, Reference Cai16–Reference Rothe18]. Children (<15 years old) accounted for a minor proportion of the infected in the pre-lockdown period. This could be because of higher vulnerability of infection among the elderly or could be attributed to the fact that children were more likely to be asymptomatic/mildly symptomatic and may not have been detected during the early stage of the epidemic [Reference Li6]. However, in the post-lockdown period, children constituted approximately one-fifth of all patients. This corroborates with published reports [Reference Dong19]. Thus, we recommend that existing surveillance mechanism should also include children under its radar as the mild/asymptomatic children may act as potential source for human-to-human transmissions.

We detected an R 0 of 2.06, indicating that each index case would give rise to approximately two secondary cases, if the surrounding population (family members in the context of current study) was completely susceptible. Given the narrow CI, we can conclude that the infection is likely to result in a sustained epidemic in Beijing (or at least in similar case family clusters), unless appropriate interventions are put in place. The R 0 value is similar to that reported from a study conducted on COVID-19 outbreak in a cruise ship (R 0 = 2.28) [Reference Zhang20]. This is expected as, from the perspective of human-to-human transmission of infection, cruise ship passengers and family clusters are likely to have similar risk characteristics. Also, the R 0 value is within the range of possible R 0 (1.4–2.5) reported by the WHO [21] and other publications based on early stage epidemic in China [Reference Li17]. Nevertheless, as the epidemic progresses, the R 0 is likely to evolve as well and its value may need to be reassessed [Reference Delamater11, Reference Das22]. The R 0 estimated by us constitute an important component of the transmission dynamics of COVID-19 in Beijing, especially for local level transmissions (stage-II of an epidemic), and may serve as a critical reference point for epidemic control measures in Beijing. Furthermore, the incubation period and serial interval in this study were found to be slightly lower than that reported from Wuhan [Reference Li6, Reference Zhang8]. Nonetheless, the estimates are quite close to Wuhan and the slight decrease may be attributed to the difference in study population between Wuhan-based studies (population-based) and the current study (index case family cluster).

The significant decrease noted in the intervals for onset-to-care-seeking and onset-to-hospital admission could be consequences of system-level (increased surveillance activities for case detection) as well as individual-level (increased public awareness about the disease and its symptoms) factors. This augur well for epidemic control measures as earlier care-seeking and hospitalisation suggests that infected patients, including asymptomatic individuals, are put on treatment/isolation more rapidly, which is likely to limit possible sources of infection.

The study had a few limitations. The inferences are drawn from a relatively small sample of family clusters. Although we admit that data scarcity may influence the precision of the results, the sample size was not much inferior from some other studies reporting on epidemiologic parameters of COVID-19 outbreak [Reference Li6]. Furthermore, the sample size appears more acceptable given the scope of the study, which was to assess the parameters for the case family clusters rather than the entire susceptible population. Second, although we followed established methods for estimating the epidemiologic parameters, the results were dependent on several modelling assumptions including the assumptions about distributions. Additionally, it is possible that the time to diagnosis and hospitalisation may have been underestimated as these were estimated from the close contacts of index cases. However, given the increased awareness following the detection of the index case, the family members were expected to have COVID-19 tests quickly, if not immediately. Therefore, even if present, we consider that the extent of underestimation to be small. Finally, as with most research reporting on R 0 of an infectious disease, the current study also assumed that the secondary cases arose from a completely susceptible population and the sources of infection for all secondary cases were respective index cases. These assumptions are unlikely to hold true in a real-world scenario.

Conclusion

Notwithstanding the limitations, our study provides reliable estimates of several epidemiologic parameters of COVID-19 outbreak in index case family clusters in Beijing, China. Although several publications have reported on different epidemiologic parameters from China, the current study stands out for couple of reasons: (1) this is one of the first explorations of COVID-19 transmission dynamics from non-Wuhan data (collected from the national capital and largest city in China) and (2) the study data are derived from index case family clusters, which may mimic the post-lockdown scenario (as the families may be largely confined within their homes and practicing social distancing) better than population-based data. Despite its limited sample size, the findings of the current study will contribute to the existing body of evidence on COVID-19 outbreak and will help in devising appropriate public health strategies for the city of Beijing (and other Chinese metropolises).

Acknowledgements

The authors thank all physicians who participated in the management of these patients.

Author contributions

WX conceived and designed the study; WX and YC collected the data; YC and YW carried out the statistical analysis, discussed the results and drafted the first manuscript. Aritra Das discussed the results, interpreted the data and modify the first manuscript. CQP supervised the data collection and interpreted the data. All authors have read and gave final approval for publication.

Financial support

This research has not received any financial support.

Conflict of interest

The authors declare no competing interests.

Ethical standards

Ethics of the study was approved by the Institutional Review Board of Beijing Ditan Hospital, Capital Medical University in Beijing (approval number: 2020-015-01). The Institutional Review Board has also approved waiver of informed consent since the study posed minimal risk to enrolees.

Disclaimer

The IQVIA had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; preparation, review or approval of the manuscript; or decision to submit the manuscript for publication.

Data availability statement

The data that support the findings of this study are available from the corresponding author on reasonable request. Participant data without names and identifiers may be shared with other researchers after approval from the corresponding author and the authorities including the Institutional Review Board and National Health Commission.

Footnotes

*

Ying Cao and Yueh Wang contributed equally to this paper.

References

The 2019-nCoV Outbreak Joint Field Epidemiology Investigation Team QL (2020) An outbreak of NCIP (2019-nCoV) infection in China – Wuhan, Hubei Province, 2019–2020. China CDC Weekly 2, 79–80.CrossRefGoogle Scholar
Zhu, N et al. (2020) A novel coronavirus from patients with pneumonia in China, 2019. The New England Journal of Medicine 382, 727–733.CrossRefGoogle Scholar
World Health Organization (2020) Coronavirus disease 2019 (COVID-19) situation report–79. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200408-sitrep-79-covid-19.pdf?sfvrsn=4796b143_6 (Accessed 9 April 2020).Google Scholar
National Health Commission of the People's Republic of China (2020) Update on COVID-19 as of 24:00 on April 8, 2020. http://www.nhc.gov.cn/xcs/yqtb/202004/fa7bb40a7fbf4b2c8f3989d512fe5b77.shtml (Accessed 9 April 2020).Google Scholar
Chan, JF et al. (2020) A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet (London, England) 395, 514–523.CrossRefGoogle ScholarPubMed
Li, Q et al. (2020) Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. The New England Journal of Medicine 382, 1199–1207.CrossRefGoogle ScholarPubMed
Sanche, S et al. (2020) High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2. Emerging Infectious Diseases 26, 1470–1477.CrossRefGoogle ScholarPubMed
Zhang, J et al. (2020) Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study. The Lancet Infectious Diseases 20, 793–802.CrossRefGoogle ScholarPubMed
Zhao, S et al. (2020) Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak. International Journal of Infectious Diseases 92, 214–217.CrossRefGoogle ScholarPubMed
Linton, NM et al. (2020) Incubation period and other epidemiological characteristics of 2019 novel coronavirus infections with right truncation: a statistical analysis of publicly available case data. Journal of Clinical Medicine 9, 538.CrossRefGoogle ScholarPubMed
Delamater, PL et al. (2019) Complexity of the basic reproduction number (R 0). Emerging Infectious Diseases 25, 1–4.CrossRefGoogle Scholar
Yao, H et al. (2020) Patient-derived mutations impact pathogenicity of SARS-CoV-2. medRxiv. doi: https://doi.org/10.1101/2020.04.14.20060160.Google Scholar
Lauer, SA et al. (2020) The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Annals of Internal Medicine 172, 577–582.CrossRefGoogle ScholarPubMed
Wallinga, J et al. (2007) How generation intervals shape the relationship between growth rates and reproductive numbers. Proceedings of the Royal Society B-Biological Sciences 274, 599–604.CrossRefGoogle ScholarPubMed
Ma, J (2020) Estimating epidemic exponential growth rate and basic reproduction number. Infectious Disease Modelling 5, 129–141.CrossRefGoogle ScholarPubMed
Cai, QC et al. (2006) Refined estimate of the incubation period of severe acute respiratory syndrome and related influencing factors. American Journal of Epidemiology 163, 211–216.CrossRefGoogle ScholarPubMed
Li, C et al. (2020) Asymptomatic and human-to-human transmission of SARS-CoV-2 in a 2-family cluster, Xuzhou, China. Emerging Infectious Diseases 26, 1626–1628.CrossRefGoogle Scholar
Rothe, C et al. (2020) Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. The New England Journal of Medicine 382, 970–971.CrossRefGoogle ScholarPubMed
Dong, Y et al. (2020) Epidemiology of COVID-19 among children in China. Pediatrics 145, e20200702.CrossRefGoogle ScholarPubMed
Zhang, S et al. (2020) Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: a data-driven analysis. International Journal of Infectious Diseases 93, 201–204.CrossRefGoogle ScholarPubMed
World Health Organization (2020) Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. https://www.who.int/health-topics/coronavirus/laboratory-diagnostics-for-novel-coronavirus.Google Scholar
Das, A (2020) An approximation-based approach for periodic estimation of effective reproduction number: a tool for decision-making in the context of coronavirus disease 2019 (COVID-19) outbreak. Public Health 185, 199–201.CrossRefGoogle ScholarPubMed
Figure 0

Fig. 1. Cumulative incident cases by 10 days since first infection.

Figure 1

Fig. 2. Serial interval empirical distribution.

Figure 2

Fig. 3. Incubation period distribution (fitted using log-normal distribution).

Figure 3

Fig. 4. Distributions of onset-to-care-seeking interval (fitted using Weibull distribution).

Figure 4

Fig. 5. Distributions of onset-to-hospital admission interval (fitted using Weibull distribution).

Figure 5

Table 1. Demographics of family clusters with COVID-19 in Beijing as of 14 February 2020